2022 SCOA Annual Meeting Sponsors

Corporate Partner:
​Sharecare Health Data Services provides secure electronic exchange, delivery and integration of protected health information, with the latest compliance standards and unmatched multi-step quality control processes. Sharecare Health Data Services delivers a variety release of information, electronic health record, disability and FMLA form processing, and billing office workflow services.

Silver Sponsors: ​

Infinx provides innovative and scalable patient access and revenue cycle management lifecycle solutions for orthopedic practices. Combining an intelligent, cloud-based platform driven by artificial intelligence and automation, with our trained and certified prior authorization, coding and billing specialists, we help clients realize revenue, enabling them to shift focus from administrative details to billable patient care. Visit www.infinx.com for more information.

Bronze Sponsors: ​

​Anika is a global joint preservation company committed to delivering meaningful advancements in early intervention orthopedic care, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Anika. Restore Active Living. Arthrosurface and Parcus have joined Anika.
Cerapedics is an advanced orthobiologics company with i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) which is only the second FDA PMA approved bone graft on the market, and its novel mechanism of action (Attract, Attach, Activate) has shown to be statistically superior to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years.
Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.
​DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve.
EPM, LLC - Medacta USA & LINKBio Corp
Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient. 
​Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, VuMedi, YouTube and Instagram.
Medtronic
A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.
We engineer the extraordinary to alleviate pain, restore health, and extend life.
Learn more at Medtronic.com
MicroPort Orthopedics ​specializes in innovative total joint replacement solutions including the Evolution® Medial Pivot Knee System and Anterior PATH tissue-sparing approach supported by our Episode of Care philosophy.
At MicroPort Orthopedics, we are continually driven to leverage our extensive experience in orthopedics and 20 years of superior clinical results to improve patient outcomes and drive provider satisfaction across the globe.
​Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, visit www.pacira.com.
Copper Sponsors: 
​ATI Physical Therapy is a nationally recognized rehabilitation provider specializing in research-based physical therapy, workers’ compensation rehab, employer worksite solutions, sports medicine and a variety of specialty therapies.
LimaCorporate is a global orthopedics company headquartered in Italy with a focus on leveraging digital innovation and tailored hardware to advance patient centered care in joint replacement surgery.  LimaCorporate’s reconstruction portfolio spans shoulder, elbow, hip, and knee arthroplasty.

For over 50 years LimaCorporate has led with a pioneering vision.  From the 3D printing of Titanium implants to Point of Care manufacturing on hospital grounds and sensor-based surgical guidance solutions, we work alongside surgeons to constantly chart new territory in medical technology.  

Stop by our booth or visit our website to see how LimaCorporate combines its passion and people with Italian design and a deep engineering heritage to help you restore the eMotion of Motion in your patients. 
SI-BONE, Inc. is a leading medical device company that has developed the iFuse Implant System®, a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint. The iFuse Implant, available since 2009, is the only device for treatment of SI joint dysfunction supported by significant published clinical evidence, including level 1 trials, showing safety, effectiveness and durability, including lasting pain relief.
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.